Skip to main content

The EOI for human insulin now revised to include long-acting insulin analogues

News
17 May, 2022 - 21:30 (CEST)
M

The changes to the EOI for human insulin shown below in bold and italic

  1. Human insulin injection (soluble) 40 IU/ mL in 10-mL vial; 100 IU/ mL in 10-mL vial and cartridge.
  2. Human intermediate-acting insulin 40 IU/ mL in 10-mL vial; 100 IU/ mL in 10-mL vial and cartridge (as compound insulin zinc suspension or isophane insulin).
  3. Long-acting insulin analogues solution for injection 100 U/mL vial and 100 U/mL in 3 mL cartridge.